Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) hit a new 52-week low on Monday . The stock traded as low as $4.65 and last traded at $4.87, with a volume of 574241 shares. The stock had previously closed at $4.13.
Evotec Stock Performance
The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The company has a market capitalization of $1.50 billion, a price-to-earnings ratio of 10.83 and a beta of 0.98. The firm has a 50-day simple moving average of $3.94 and a two-hundred day simple moving average of $4.33.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- Trading Stocks: RSI and Why it’s Useful
- Rocket Lab is the Right Stock for the Right Time
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
